N-[12-[(7-NITRO-2-1,3-BENZOXADIAZOL-4-YL)AMINO]DODECANOYL]-CERAMIDE structure
|
Common Name | N-[12-[(7-NITRO-2-1,3-BENZOXADIAZOL-4-YL)AMINO]DODECANOYL]-CERAMIDE | ||
---|---|---|---|---|
CAS Number | 202850-01-9 | Molecular Weight | 659.899 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C36H61N5O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of N-[12-[(7-NITRO-2-1,3-BENZOXADIAZOL-4-YL)AMINO]DODECANOYL]-CERAMIDEC12-NBD-ceramide is a fluorescent analogue of ceramide, it can be used as a substrate in ceramidase assays[1][2]. |
Name | N-[1-hydroxy-14-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]tetradec-4-en-2-yl]hexadecanamide |
---|---|
Synonym | More Synonyms |
Description | C12-NBD-ceramide is a fluorescent analogue of ceramide, it can be used as a substrate in ceramidase assays[1][2]. |
---|---|
Related Catalog | |
In Vitro | Guidelines (Following is our recommended protocol. This protocol only provides a guideline, and should be modified according to your specific needs). In this experiment, C12-NBD-ceramide is used as a fluorescent nCDase substrate and reaction products will be separated by reverse-phase HPLC[2]: 1. 20 µM substrate, 1 nM nCDase in 75 mM NaCl, 25 mM HEPES (pH 8.0), and 0.4% Triton X-100, for 2 h at 37°C in a final volume of 100 µL. 2. Extract samples with 1:1 chloroform-methanol dries under nitrogen gas, and resuspends in 60 µL of HPLC mobile phase B. Separats reaction products by reverse-phase HPLC using a Spectra 3 µm C8SR column (3 μm particle, 3.0 × 150 mm). 3. Mobile phase A contains 0.2% formic acid and 1 mM ammonium formate in HPLC-grade water. Mobile phase B contains 0.2% formic acid (IL) and 1 mM ammonium formate in HPLC-grade methanol. 4. FRET-based assay using 20 µM substrate ES.173.cds, 50 ng of nCDase, 75 mM NaCl, 15 mM sodium phosphate (pH 7.4), and 0.3% Triton X-100 for 3 h in 96 black well plates. 5. Measure resorufin fluorescence (Ex=347 nm, Em=430 and 530 nm). |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Molecular Formula | C36H61N5O6 |
Molecular Weight | 659.899 |
Exact Mass | 659.462158 |
PSA | 166.33000 |
LogP | 11.44 |
Index of Refraction | 1.547 |
Dodecanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]- |
N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]dodecanamide |